Chiaki Endo
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer-Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study.
Journal: Journal of thoracic disease
Published: August 18, 2020
Innervation of the Human Incisive Papilla: Comparison with Other Oral Regions.
Journal: Cells, tissues, organs
Published: September 04, 2017
Serum β-hCG as an Indicator of Recurrence After the Complete Resection of a Malignant Solitary Fibrous Tumor of the Pleura.
Journal: The Annals of thoracic surgery
Published: March 24, 2016
Effectiveness of a Simulation of the Donor Surgery with Other Extraction Teams to Improve Various Problems in Pulmonary Extraction from a Brain-dead Donor
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: September 03, 2015
Perioperative management of lung cancer patients with cardiovascular complications
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: April 04, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Journal: The Cochrane database of systematic reviews
Published: March 03, 2015
Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues.
Journal: The International journal of biological markers
Published: December 02, 2014
Inter-rater agreement of sputum cytology for lung cancer screening in Japan.
Journal: Diagnostic cytopathology
Published: October 16, 2014
Contribution of surgical margin for surgical outcome of the chest wall tumors
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: April 19, 2014
The prognostic significance of eukaryotic elongation factor 1 alpha-2 in non-small cell lung cancer.
The prognostic significance of eukaryotic elongation factor 1 alpha-2 in non-small cell lung cancer.
Journal: Anticancer research
Published: February 11, 2014
A randomized phase III trial of postoperative adjuvant therapy for completely resected stage IA-IIIA lung cancer using an anti‑angiogenetic agent: irsogladine maleate.
Journal: Minerva chirurgica
Published: November 07, 2013
Last Updated: 09/26/2026